title: The impact of changes in HIV management guidelines on time to treatment initiation in Australia.
authors.affiliation: The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
authors.forename: R
authors.initials: R
authors.lastname: Puhr
authors.affiliation: The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
authors.forename: K
authors.initials: K
authors.lastname: Petoumenos
authors.affiliation: Gladstone Road Medical Centre, Highgate Hill, QLD, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Youds
authors.affiliation: The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
authors.forename: M G
authors.initials: MG
authors.lastname: Law
authors.affiliation: The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.|RPA Sexual Health, Sydney Local Health District and Central Clinical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: D J
authors.initials: DJ
authors.lastname: Templeton
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D001315:Australia / Q000453:epidemiology; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D061665:Time-to-Treatment / Q000639:trends*; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents